Bioscience Chapter Database :: 3543 Chapters Now Online

Chapter category:

Is Leptin a Pro‑ or Anti‑Apoptotic Agent?

This chapter appears in the following book:

Leptin and Leptin Antagonists

Edited by: Arieh Gertler
ISBN: TBA
» Get more information about this book at landesbioscience.com «

Chapter authors:
Srujana Rayalam, Mary Anne Della-Fera, Suresh Ambati and Clifton A. Baile


[+] view image
Apoptosis, the regulated destruction of a cell, is characterized by biological and morphological changes and involves a large web of integrating pathways and factors. Apoptosis is necessary to eliminate excess cells and cells that hinder development and hence the importance of apoptotic pathways and apoptotic agents in removing adipocytes for the treatment of obesity has been recently explored. Leptin was widely recognized for its ability to regulate adipose tissue mass by influencing food intake and energy expenditure. Recent findings, however, demonstrated that leptin treatment initiated apoptosis in adipose tissue. Leptin‑induced adipocyte apoptosis was a surprising finding, as adipocytes were thought to be extremely stable; however, both pro‑ and anti‑anti‑apoptotic effects of leptin have been demonstrated in several cell types. In particular, anti‑apoptotic effects have been shown in certain types of cancer cells and are correlated with the presence of leptin receptors. While leptin’s effects on energy balance, including induction of adipocyte apoptosis, are primarily mediated by the central nervous system, it is possible that anti‑apoptotic effects of leptin are mediated through autocrine or paracrine effects. In this chapter both anti‑apoptotic and pro‑apoptotic effects of leptin in several cell types are reviewed.

Srujana Rayalam

Mary Anne Della-Fera

Suresh Ambati

Clifton A. Baile
Department of Animal and Dairy Science and Department of Foods and Nutrition, University of Georgia, Athens, GA

» Access chapter for $19



Additional chapters from this book:

The Use of Leptin for the Treatment of Lipodystrophy

Angeline Y. Chong, Elaine K. Cochran and Phillip Gorden

Leptin was the first of the adipocyte‑secreted hormones, later termed adipokines, to be identified. It is used clinically to treat hypoleptinemic states, such as congenital leptin deficiency and...

Study of Leptin: Leptin Receptor Interaction by FRET and BRET

Julie Dam, Cyril Couturier, Patty Chen and Ralf Jockers

Understanding the molecular mechanism of the leptin:leptin receptor (OB‑R) interaction and the OB‑R activation process is crucial for the development of drugs that target OB‑Rs. Rece...

Leptin as a Novel Marker in Breast and Colorectal Cancer

Eva Surmacz and Mariusz Koda

Obesity, defined as Body Mass Index (BMI) ≥30, constitutes a known risk factor for the development of different neoplasms, including such common diseases as postmenopausal breast cancer and colo...

Leptin Signal Transduction—A 2008 Update

Walter Becker

Leptin is an adipocyte‑secreted hormone that informs the brain about the status of the body’s energy stores. Leptin controls energy homeostasis through effects on satiety and energy expenditure ...

Is Leptin a Pro‑ or Anti‑Apoptotic Agent?

Srujana Rayalam, Mary Anne Della-Fera, Suresh Ambati and Clifton A. Baile

Apoptosis, the regulated destruction of a cell, is characterized by biological and morphological changes and involves a large web of integrating pathways and factors. Apoptosis is necessary to elimina...


SIGN IN

Email:


Password:


lost password?




[ Home | Authors | Editors | Custom Books | Chapter Reprints | Subscribe | Contact | Biotoons ]